Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.91
+0.11 (1.62%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $443.28 million as of April 14, 2026. Its market cap has increased by 48.58% in one year.
Market Cap
443.28M
Enterprise Value
316.42M
1-Year Change
48.58%
Ranking
Category
Stock Price
$6.91
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $443.28M, an increase of 11.45%. That is a compound annual growth rate of 2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 443.28M | 28.08% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 454.23M |
| vTv Therapeutics | 453.69M |
| Atea Pharmaceuticals | 451.74M |
| Assembly Biosciences | 450.82M |
| Lexeo Therapeutics | 443.04M |
| YD Bio | 440.20M |
| XOMA Royalty | 437.78M |
| Sutro Biopharma | 428.43M |